205 related articles for article (PubMed ID: 33079484)
1. Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review.
Jia M; Zhang X; Wei L; Gao J
Asia Pac J Clin Oncol; 2021 Aug; 17(4):321-329. PubMed ID: 33079484
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, mechanisms, and management of cancer-related cognitive impairment.
Janelsins MC; Kesler SR; Ahles TA; Morrow GR
Int Rev Psychiatry; 2014 Feb; 26(1):102-13. PubMed ID: 24716504
[TBL] [Abstract][Full Text] [Related]
3. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
[TBL] [Abstract][Full Text] [Related]
4. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.
Yao S; Zhang Q; Yao X; Zhang X; Pang L; Yu S; Cheng H
Breast Cancer Res Treat; 2023 Aug; 201(1):15-26. PubMed ID: 37329458
[TBL] [Abstract][Full Text] [Related]
5. Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.
Onzi GR; D'Agustini N; Garcia SC; Guterres SS; Pohlmann PR; Rosa DD; Pohlmann AR
Drug Saf; 2022 Jun; 45(6):601-621. PubMed ID: 35606623
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
Wefel JS; Kesler SR; Noll KR; Schagen SB
CA Cancer J Clin; 2015 Mar; 65(2):123-38. PubMed ID: 25483452
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
8. Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.
Kiesl D; Kuzdas-Sallaberger M; Fuchs D; Brunner S; Kommenda R; Tischler C; Hornich H; Akbari K; Kellermair J; Blessberger H; Ocenasek H; Hofmann P; Zimmer P; Vosko MR
Front Neurol; 2022; 13():777808. PubMed ID: 35401389
[TBL] [Abstract][Full Text] [Related]
9. A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
Syed Alwi SM; Mazlan M; Mohd Taib NA; Che Din N; Narayanan V
PLoS One; 2022; 17(11):e0277056. PubMed ID: 36395277
[TBL] [Abstract][Full Text] [Related]
10. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-related cognitive impairment in older patients with cancer.
Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021.
Amani O; Mazaheri MA; Moghani MM; Zarani F; Choolabi RH
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1989. PubMed ID: 38351543
[TBL] [Abstract][Full Text] [Related]
13. [Cancer-related Cognitive Impairment: Current Knowledge and Future Challenges].
Tanimukai H
Seishin Shinkeigaku Zasshi; 2015; 117(8):585-600. PubMed ID: 26642725
[TBL] [Abstract][Full Text] [Related]
14. Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer.
Bolton G; Isaacs A
Psychol Health Med; 2018 Dec; 23(10):1261-1274. PubMed ID: 30048158
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
16. Predicting Patient Reported Outcomes of Cognitive Function Using Connectome-Based Predictive Modeling in Breast Cancer.
Henneghan AM; Gibbons C; Harrison RA; Edwards ML; Rao V; Blayney DW; Palesh O; Kesler SR
Brain Topogr; 2020 Jan; 33(1):135-142. PubMed ID: 31745689
[TBL] [Abstract][Full Text] [Related]
17. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
18. Patients With Breast Cancer Receiving Chemotherapy: Effects of Multisensory Stimulation Training on Cognitive Impairment.
Li Z; Hao X; Lei P; Zhou L; Chen C; Tan T; Yue L
Clin J Oncol Nurs; 2022 Feb; 26(1):71-77. PubMed ID: 35073301
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy.
Cerulla Torrente N; Navarro Pastor JB; de la Osa Chaparro N
J Cancer Surviv; 2020 Aug; 14(4):464-482. PubMed ID: 32146576
[TBL] [Abstract][Full Text] [Related]
20. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy.
Williams AM; Shah R; Shayne M; Huston AJ; Krebs M; Murray N; Thompson BD; Doyle K; Korotkin J; van Wijngaarden E; Hyland S; Moynihan JA; Cory-Slechta DA; Janelsins MC
J Neuroimmunol; 2018 Jan; 314():17-23. PubMed ID: 29128118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
